Teladoc Health Inc (NYSE:TDOC) shares traded 2.63% higher at $10.14 on Wall Street last session.
TDOC stock price is now 1.77% away from the 50-day moving average and 2.50% away from the 200-day moving average. The market capitalization of the company currently stands at $1.75B.
With the price target of $14, Goldman recently initiated with Buy rating for Teladoc Health Inc (NYSE: TDOC). On September 17, 2024, Jefferies reiterated its ‘Hold’ rating on the stock by increasing its target price from $8 to quote $10, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
In other news, Nanis Nikolaos P., Officer bought 502 shares of the company’s stock on Jan 03 ’25. The stock was bought for $4,681 at an average price of $9.33. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 16 ’24, Officer Waters Michael Willem bought 4,652 shares of the business’s stock. A total of $47,823 was incurred on buying the stock at an average price of $10.28. A total of 2.12% of the company’s stock is owned by insiders.
During the past 12 months, Teladoc Health Inc has had a low of $6.76 and a high of $21.74. As of last week, the company has a debt-to-equity ratio of 1.05, a current ratio of 1.69, and a quick ratio of 1.65. The fifty day moving average price for TDOC is $9.9514 and a two-hundred day moving average price translates $9.9141 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for 2024-09-30. The net profit margin was -37.91% and return on equity was -51.65% for TDOC. The company reported revenue of $640.51 million for the quarter, compared to $660.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.99 percent. For the current quarter, analysts expect TDOC to generate $639.66M in revenue.
